clinicaltrials.gov
Flux RSS de ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days
Reçois les dernières mises à jour de ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days dès leur publication.
Derniers articles
Retrouvez ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days là où vous lisez
Les personnes qui suivent ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days suivent également
-
Chugai Pharmaceutical: News Releases chugai-pharm.co.jp
-
Regeneron Pharmaceuticals Inc. News Releases investor.regeneron.com
-
What's new ema.europa.eu
-
Roche Media News roche.com
-
Questions
Quelle est l’URL du flux RSS de ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days ?
L’adresse du flux est https://clinicaltrials.gov/ct2/results/rss.xml?rcv_d=&lup_d=14&sel_rss=mod14&term=vedolizumab&recrs=abdf&type=Intr&phase=0124&fund=2&count=10000. Collez-la dans n’importe quel lecteur RSS ou cliquez sur Suivre maintenant pour le lire dans Feeder.
À quelle fréquence ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days publie-t-il ?
ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days publie environ une fois par semaine. La dernière publication remonte à 1 jour.
Le flux RSS de ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days fonctionne-t-il ?
Oui. Feeder l’a vérifié il y a environ une heure et le flux a répondu normalement.
Comment suivre ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days dans Feeder ?
Cliquez sur Suivre maintenant et inscrivez-vous si vous n’avez pas encore de compte. L’offre gratuite de Feeder permet de suivre jusqu’à 200 flux sur le Web, iPhone et Android. Aucune carte bancaire requise.
Suivez ClinicalTrials.gov: vedolizumab | Recruiting, Not yet recruiting, Active, not recruiting, Enrolling by invitation Studies | Interventional Studies | Phase Early Phase 1, 1, 2, 3 | Industry | Last update posted in the last 14 days dans Feeder
L’offre gratuite de Feeder permet de suivre jusqu’à 200 flux sur le Web, iPhone et Android. Aucune carte bancaire requise.